Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02795078
Other study ID # BJTTH-001
Secondary ID
Status Recruiting
Phase N/A
First received June 5, 2016
Last updated November 3, 2017
Start date October 2015
Est. completion date March 2018

Study information

Verified date November 2017
Source Ministry of Science and Technology of the People´s Republic of China
Contact liu xingju, MD
Phone 8615011476305
Email liuxingju006@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Atherosclerotic intracranial arterial(ICA) stenosis and intracranial aneurysms are the common causes of ischemic stroke and hemorrhagic stroke, respectively. Investigators aimed to assess the prevalence of cerebral aneurysms in patients with atherosclerotic intracranial arterial stenosis.


Description:

Based on prospective data of patients with symptomatic or asymptomatic ICA stenosis admitted to Beijing Tiantan Hospital between Jan 2015 and July 2016, all patients underwent brain CTA / MRA/DSA. Investigators determined the number of the patients with intracranial aneurysms, calculated overall prevalence of the coexistence of atherosclerotic ICA stenosis with aneurysms and analyzed the clinical features.


Recruitment information / eligibility

Status Recruiting
Enrollment 700
Est. completion date March 2018
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. DSA identified the coexistence of intracranial Arterial Stenosis With Intracranial Aneurysms

2. Stenosis caused by atherosclerosis

Exclusion Criteria:

1. patients do not agree

2. Stenosis caused by no atherosclerosis disease

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
conservative treatment

Procedure:
Aneurysms clipping

Interventional embolization forAneurysms

stenting for stenosis


Locations

Country Name City State
China Beijing Tiantan Hospital Capital Medical University Beijing Beijing

Sponsors (2)

Lead Sponsor Collaborator
liuxingju National Clinical Research Center for Neurological Diseases

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary new stroke events during perioperative period perioperative period
Secondary stroke events during follow up 6 months after discharge